Submit Answers

Australian Pharmacist logo

April 2020

The below online CPD modules from the current edition of Australian Pharmacist are available free for PSA members.

Cold chain management and vaccines

Australian Pharmacist – July 2020 – Supporting your practice

Pharmacists play a vital role in the distribution, dispensing and administration of life saving vaccines. For a vaccine to be effective, it needs to be stored between +2 and +8 degrees Celsius (°C) from the time of manufacture to the point of administration. The system of transporting and storing vaccines within this temperature range is known as the ‘vaccine cold chain’.

Insomnia and stress in the era of COVID-19

Australian Pharmacist – July 2020 – Chronic disease management

The world is in the grip of a pandemic as a result of COVID-19. In the absence of a vaccine and evidence-based treatments, public health strategies have been put in place to manage transmission in an attempt to halt the disease. These situations can disrupt established daily routines and affect sleep patterns resulting in acute sleep disorders such as insomnia. As pharmacies remain open, pharmacists may likely see an increase in requests for strategies to manage stress and insomnia.

Relapsing-remitting and secondary progressive multiple sclerosis

Australian Pharmacist – July 2020 – Clinical sponsored 1

Multiple sclerosis (MS) is a chronic inflammatory autoimmune condition that causes demyelination of the central nervous system (CNS). It is one of the most common conditions affecting the CNS of young adults. Symptoms may include weakness, fatigue, spasticity and ataxia which can lead to difficulties walking, bladder and bowel problems and cognitive changes. There is no cure for MS, treatments are used to manage relapses, slow the progression or help to ease symptoms.

Management of COPD

Australian Pharmacist – July 2020 – Clinical sponsored 2

COPD affects around 1 in 7 Australians, mainly older people. In 2017-18, COPD was the most common reason for potentially preventable hospitalisation. The aim of pharmacotherapy for management of COPD is to treat symptoms and prevent exacerbations. A stepwise approach is recommended, irrespective of disease severity, until adequate control has been achieved. The mainstay of pharmacological treatment for COPD is inhaled bronchodilators and corticosteroids.

Past journals

PSA members can view articles and submit answers to assessment questions from Australian Pharmacist CPD from the previous 24 months by clicking the links below.